Additional Supporting Information may be found in the online version of this article at the publisher's web-site.

pbc24761-sm-0001-SuppFig.tif65771KFigure 1. CT imaging from prior to treatment (left) and at most recent follow-up visit (right). A) Prominent pelvic lymph node (arrow), as well as soft tissue anasarca seen prior to initiating therapy; neither seen one year off therapy. B) Axillary lymphadenopathy (upper arrow) and right lower quadrant mesenteric lymphadenopathy (lower arrow) prior to initiating therapy; resolved one year off therapy. C) Inguinal lymphadenopathy (bilateral arrows); resolved one year off therapy. D) Bilateral anterior cervical lymphadenopathy (bilateral arrows); decreased in size one year off therapy. E) Bilateral anterior cervical lymphadenopathy (bilateral arrows), multiple levels; decreased in size one year off therapy.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.